| Literature DB >> 30353512 |
Yubin Du1, Wen Xie1, Fan Zhang1, Uimook Choi2, Chengyu Liu1, Colin L Sweeney3.
Abstract
NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice are an immunodeficient strain that enables human cell xenografts. However, NSG mice possess a complex genetic background that would complicate cross-breeding with other inbred transgenic or knockout mouse strains to establish a congenic strain with a desired genetic modification in the NSG background. Newly developed clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technology enables modification of the mouse genome at the zygote stage without the need for extensive cross-breeding or the use of embryonic stem cells. In this chapter, we use the knockout of the X-linked Cybb gene as an example to describe our procedures for genetically modifying NSG mice using the CRISPR/Cas9 method. Briefly, two sgRNAs were designed and made to target exon 1 and exon 3 of the Cybb gene, and either sgRNA was then microinjected together with Cas9 mRNA into fertilized eggs collected from NSG mice. The injected embryos are subsequently transferred into the oviducts of pseudopregnant surrogate mothers. Offspring born to the foster mothers were genotyped by PCR and DNA sequencing. In this chapter, we describe our experiment procedures in detail and report our genotyping results for demonstrating that NSG mice can be genetically modified using the CRISPR/Cas9 technology in a highly efficient manner.Entities:
Keywords: CRISPR/Cas9; Cybb; Genotyping; Immunodeficient mice; Knockout; Microinjection; NSG; Oviduct embryo transfer
Mesh:
Substances:
Year: 2019 PMID: 30353512 PMCID: PMC7467215 DOI: 10.1007/978-1-4939-8831-0_8
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745